FDA Inspection 1005622 — Perryman Company
The FDA completed an inspection of Perryman Company on February 9, 2017 in Houston, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 9, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Houston, PA (United States)